International Transplant Skin Cancer Collaborative
EIN: 431964114 · Milwaukee, WI · NTEE: H300
| Metric | Value |
|---|---|
| Total Revenue | $126K |
| Total Expenses | $44K |
| Net Assets | $135K |
Is International Transplant Skin Cancer Collaborative Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About International Transplant Skin Cancer Collaborative
International Transplant Skin Cancer Collaborative (EIN: 431964114) is a nonprofit organization based in Milwaukee, WI, classified under NTEE code H300. The organization reported total revenue of $126K and total assets of $224K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of International Transplant Skin Cancer Collaborative's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
International Transplant Skin Cancer Collaborative is a small nonprofit that has been operating for 23 years, with 10 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 31.9%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $66K |
| Total Expenses | $44K |
| Surplus / Deficit | +$22K |
| Total Assets | $157K |
| Total Liabilities | $22K |
| Net Assets | $135K |
| Operating Margin | 33.1% |
| Debt-to-Asset Ratio | 14.1% |
| Months of Reserves | 42.9 months |
Financial Health Grade: A
In 2023, International Transplant Skin Cancer Collaborative reported a surplus of $22K with revenue exceeding expenses, holds 42.9 months of operating reserves (strong position), has a debt-to-asset ratio of 14.1% (very low leverage).
Financial Trends
Over 10 years of filings (2011–2023), International Transplant Skin Cancer Collaborative's revenue has grown at a compound annual growth rate (CAGR) of 31.9%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -15.4% | -41.9% | +22.0% |
| 2022 | +204.6% | +343.5% | +0.2% |
| 2021 | -35.7% | -28.2% | +9.9% |
| 2020 | +5.8% | -33.5% | +10.2% |
| 2019 | +20.3% | +17.0% | -20.5% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2003 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for International Transplant Skin Cancer Collaborative has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates International Transplant Skin Cancer Collaborative with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $22K, with revenue exceeding expenses.
- Debt-to-asset ratio: 14.1%.
Frequently Asked Questions about International Transplant Skin Cancer Collaborative
Is International Transplant Skin Cancer Collaborative a legitimate charity?
International Transplant Skin Cancer Collaborative (EIN: 431964114) is a registered tax-exempt nonprofit based in Wisconsin. It has 10 years of IRS 990 filings on record. Total revenue: $126K. No red flags identified. Financial health grade: A.
How does International Transplant Skin Cancer Collaborative spend its money?
International Transplant Skin Cancer Collaborative reported $126K in total revenue in IRS 990 filings. 10 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to International Transplant Skin Cancer Collaborative tax-deductible?
International Transplant Skin Cancer Collaborative is registered as a tax-exempt nonprofit (EIN: 431964114). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is International Transplant Skin Cancer Collaborative located?
International Transplant Skin Cancer Collaborative is headquartered in Milwaukee, Wisconsin and files with the IRS under EIN 431964114. It is classified under NTEE code H300.
How many years of IRS 990 filings does International Transplant Skin Cancer Collaborative have?
International Transplant Skin Cancer Collaborative has 10 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $126K in total revenue.
Filing History
IRS 990 filing history for International Transplant Skin Cancer Collaborative showing financial trends over 10 years of public records:
Over 10 years of IRS 990 filings (2011–2023), International Transplant Skin Cancer Collaborative's revenue has grown by 2669.2%, moving from $2K to $66K. Total assets decreased by 11.4% over the same period, from $177K to $157K. Total functional expenses rose by 97.5%, from $22K to $44K. In its most recent filing year (2023), International Transplant Skin Cancer Collaborative reported a surplus of $22K, with revenue exceeding expenses. The organization holds $22K in liabilities against $157K in assets (debt-to-asset ratio: 14.1%), resulting in net assets of $135K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $66K | $44K | $157K | $22K | — | — |
| 2022 | $77K | $75K | $129K | $15K | — | View 990 |
| 2021 | $25K | $17K | $128K | $17K | — | View 990 |
| 2020 | $40K | $24K | $117K | $14K | — | View 990 |
| 2019 | $37K | $36K | $106K | $19K | — | View 990 |
| 2015 | $31K | $30K | $133K | $67 | — | View 990 |
| 2014 | $71K | $60K | $133K | $154 | — | View 990 |
| 2013 | $16K | $28K | $124K | $2K | — | View 990 |
| 2012 | $6K | $48K | $135K | $700 | — | View 990 |
| 2011 | $2K | $22K | $177K | $456 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $66K, expenses of $44K, and assets of $157K (revenue -15.4% year-over-year).
- 2022: Revenue of $77K, expenses of $75K, and assets of $129K (revenue +204.6% year-over-year).
- 2021: Revenue of $25K, expenses of $17K, and assets of $128K (revenue -35.7% year-over-year).
- 2020: Revenue of $40K, expenses of $24K, and assets of $117K (revenue +5.8% year-over-year).
- 2019: Revenue of $37K, expenses of $36K, and assets of $106K (revenue +20.3% year-over-year).
- 2015: Revenue of $31K, expenses of $30K, and assets of $133K (revenue -56.1% year-over-year).
- 2014: Revenue of $71K, expenses of $60K, and assets of $133K (revenue +355.6% year-over-year).
- 2013: Revenue of $16K, expenses of $28K, and assets of $124K (revenue +145.4% year-over-year).
- 2012: Revenue of $6K, expenses of $48K, and assets of $135K (revenue +167.4% year-over-year).
- 2011: Revenue of $2K, expenses of $22K, and assets of $177K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for International Transplant Skin Cancer Collaborative:
Data Sources and Methodology
This transparency report for International Transplant Skin Cancer Collaborative is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.